Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Completed · Not applicable
Conditions studied: Primary Open-angle Glaucoma
In brief
Evaluate the safety and efficacy of the Glaukos® Suprachoroidal Stent Model G3 in conjunction with cataract surgery, compared to cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.
Key facts
- Study ID
- NCT01461278
- Run by
- Glaukos Corporation
- People needed
- 505
- Starts
- 2011-12-22
- Expected to finish
- 2020-03-12
- Last updated by the study team
- 2022-05-19
Who can join
Age: 45 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Mild to moderate open-angle glaucoma
- Characteristics consistent with mild to moderate glaucoma
- Use of one (1) to three (3) medications at time of screening exam
You may not qualify if…
- Pigmentary or pseudoexfoliative glaucoma
- Prior incisional glaucoma surgery
Where it is running
- Eye Centers of Racine and Kenosha — Racine, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.